Head and Neck Cancer
Showing NaN - NaN of 60
Head Neck Cancer, Squamous Cell Cancer Trial in Worldwide (Zalutumumab, Control)
Completed
- Head and Neck Cancer
- Squamous Cell Cancer
- Zalutumumab
- Control
-
Antwerp, Belgium
- +81 more
Aug 9, 2013
Breast Cancer, Colorectal Cancer, Esophageal Cancer Trial in London (other, procedure, radiation)
Unknown status
- Breast Cancer
- +4 more
- 18F-fluoromisonidazole
- +8 more
-
London, England, United KingdomUniversity College Hospital
Aug 23, 2013
Head Neck Cancer Trial in India, United Kingdom (biological, drug, radiation)
Completed
- Head and Neck Cancer
- bleomycin sulfate
- +7 more
-
Indore, India
- +6 more
Aug 1, 2013
NSCLC, Breast Cancer, Head Neck Cancer Trial in Canada (PET/CT scan)
Completed
- Non-small Cell Lung Cancer
- +5 more
- PET/CT scan
-
Hamilton, Ontario, Canada
- +3 more
Feb 15, 2013
Head Neck Cancer, Pain Trial in London (Intervention)
Unknown status
- Head and Neck Cancer
- Pain
- Intervention
-
London, United KingdomRoyal Marsden Hospital
Oct 25, 2012
Head Neck Cancer Trial in Worldwide (liposomal lurtotecan)
Completed
- Head and Neck Cancer
- liposomal lurtotecan
-
Vienna (Wien), Austria
- +19 more
Jul 23, 2012
Head Neck Cancer, Squamous Cell Carcinoma Trial in Belgium, France, United Kingdom (Zalutumumab)
Terminated
- Head and Neck Cancer
- Squamous Cell Carcinoma
-
Brussels, Belgium
- +7 more
Nov 21, 2011
Head Neck Cancer Trial in London (docetaxel, everolimus, laboratory biomarker analysis)
Terminated
- Head and Neck Cancer
- docetaxel
- +3 more
-
London, England, United KingdomUCL Cancer Institute
Dec 9, 2011
Head Neck Cancer, Radiation Toxicity, Xerostomia Trial in United Kingdom (management of therapy complications, radiation
Unknown status
- Head and Neck Cancer
- +2 more
- management of therapy complications
- radiation therapy
-
Cambridge, England, United Kingdom
- +8 more
Mar 22, 2011
Head Neck Cancer, Ototoxicity, Radiation Toxicity Trial in London (adjuvant therapy, assessment of therapy complications,
Unknown status
- Head and Neck Cancer
- +2 more
- adjuvant therapy
- +4 more
-
London, England, United KingdomRoyal Marsden - London
Oct 6, 2010